Log In
BCIQ
Print this Print this
 

CTT-54

  Manage Alerts
Collapse Summary General Information
Company Cancer Targeted Technology LLC
DescriptionPET imaging agent
Molecular Target Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPreclinical
Standard IndicationCancer, Diagnostic
Indication DetailsDetect cancer; Diagnose prostate cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today